|
|
| REPORTERS
OFFERED FOR SERVICES AND LICENSE |
On
this page... |
|
|
|
|
|
|
|
| FUNCTIONAL REPORTER
CELL LINES AND CONSTRUCTS |
|
| |
|
REAL
TIME IN VIVO IMAGING OF APOPTOSIS |
|
|
|
MIR's caspase activation assays generate in vivo bioluminescence
or fluorescence-based readouts of apoptosis. These assays
yield real time in vivo imaging of drug function, requiring
fewer animals and produces tighter correlations than excision
based immunologic readouts. Bioluminescence imaging increase
both detection sensitivity and imaging throughput. MIR
is offering this technology for license as well as a contract
research service. This technology is available exclusively
through MIR. |
|
|
| |
|
|
How
does this technology work? |
|
The left figure depicts cells are stably transfected
with a luciferase construct that is fused with ER.
The ER silences luciferase activity due to sequestration.
Activation of caspase 3 during apoptosis results in
cleavage at DEVD site releasing luciferase. Free luciferase
can now (in the presence of luciferin) generate bioluminescence
which can be imaged in vitro and in vivo using a Xenogen
imaging system. The left figure depicts cells can
stably transfected with a lac Z construct that is
fused with ER that silences lac Z. Activation of caspase
3 during apoptosis results in cleavage at DEVD site
releasing lac Z which can now (in the presence of
DDAOG) generate fluorescence which can be imaged in
vitro and in vivo using a Xenogen imaging system.
|
|
|
| |
|
 |
|
|
Caspase activation in luciferase
based assay correlated with increased bioluminescence
|
Caspase activation in Lac-z based
assay correlated with increased fluorescence
|
Caspase activation in luciferase
based assay correlated with increased bioluminescence
|
|
|
|
|
| CONSTITUITIVE
REPORTER MODELS |
|
| |
|
MIR has a number of cell lines that constitutively
express luciferase. These models are well suited for
orthotopic and metastatic studies. Below is a list of
luciferase producing cell lines that MIR offers for
services:
-
B16-luc
-
PC3-luc
-
MDA-MB-231-luc
-
SK-OV-3-luc
Other cell lines are in the process of being validated.
Please contact MIR for more information on these upcoming
models. |
|
|
|
|